Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011319
Filing Date
2025-08-13
Accepted
2025-08-13 10:18:27
Documents
77
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dwtx-20250630x10q.htm   iXBRL 10-Q 1473231
2 EX-10.1 dwtx-20250630xex10d1.htm EX-10.1 105644
3 EX-31.1 dwtx-20250630xex31d1.htm EX-31.1 12218
4 EX-31.2 dwtx-20250630xex31d2.htm EX-31.2 12100
5 EX-32.1 dwtx-20250630xex32d1.htm EX-32.1 6787
6 EX-32.2 dwtx-20250630xex32d2.htm EX-32.2 6794
  Complete submission text file 0001558370-25-011319.txt   7641160

Data Files

Seq Description Document Type Size
7 EX-101.SCH dwtx-20250630.xsd EX-101.SCH 49698
8 EX-101.CAL dwtx-20250630_cal.xml EX-101.CAL 65823
9 EX-101.DEF dwtx-20250630_def.xml EX-101.DEF 232891
10 EX-101.LAB dwtx-20250630_lab.xml EX-101.LAB 490487
11 EX-101.PRE dwtx-20250630_pre.xml EX-101.PRE 386714
80 EXTRACTED XBRL INSTANCE DOCUMENT dwtx-20250630x10q_htm.xml XML 1217665
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39811 | Film No.: 251209425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)